ICG dye mapping to find lymph nodes in some childhood tumors
Treatments studied
Part of Cancer clinical trials.
This early study tests using a special dye (indocyanine green, or ICG) to help surgeons find the correct “sentinel” lymph nodes during surgery in children with certain suspected tumors. If successful, it may improve how doctors remove and check lymph nodes while reducing the chance of missing important areas.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be under age 21 and have a suspected visceral (inside the belly) solid tumor that could be Wilms tumor or para-testicular rhabdomyosarcoma
- Be scheduled to need surgery that includes removing retroperitoneal lymph nodes (lymph node dissection in the back of the belly)
- No history of allergy to iodide (iodine-related substances)
- A parent/guardian must be able and willing to sign written consent for the study
- Not be pregnant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new way to map lymph nodes in children with solid tumors, using a tracer to help doctors see which nodes to remove. The goal is to make lymph node sampling safer and more accurate, which could help guide treatment decisions.
This trial tests if an injection of indocyanine green dye can help surgeons find and remove only the key lymph nodes in the armpit during breast cancer surgery. It aims to reduce the need for more extensive lymph node removal.
This trial tests using a green dye called ICG (indocyanine green) during breast cancer surgery to find the first lymph nodes (sentinel nodes) that cancer may have spread to. It aims to help doctors locate these nodes more accurately, and is for people with early-stage breast cancer that has not yet spread to the lymph nodes.
This study tests using a green dye (called ICG) injected near your vulvar tumor during surgery to help the surgeon see and remove the right lymph nodes. This could help avoid removing too many lymph nodes and reduce side effects.
This trial tests whether a special dye (ICG) seen during your surgery can help doctors better identify the edges of a tumor in bone or soft tissue. It may help ensure as much of the tumor is removed as safely as possible.
This trial uses a special dye called ICG that is injected during surgery to help the surgeon see the blood flow to your colon and lymph nodes. It may help make the surgery more precise and improve outcomes for colon cancer.
Hear when a new Solid Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.